Cees Wortel

Privat kapitalinvesterare på

Vesalius Biocapital Partners SARL

Health Technology

Consumer Services

Finance

Profil

Cees Wortel currently works at Vesalius Biocapital Partners SARL, as Venture Partner from 2016.
Dr. Wortel also formerly worked at Galapagos NV, as Chief Medical Officer.
Dr. Wortel received his doctorate degree in 1993 from the University of Amsterdam.

Aktiva positioner av Cees Wortel

Företag	Position	Start
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Privat kapitalinvesterare	2016-01-01

Alla aktiva positioner av Cees Wortel

Tidigare kända positioner av Cees Wortel

Företag	Position	Slut
LAKEFRONT BIOTHERAPEUTICS NV	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Cees Wortels erfarenhet

Cees Wortels utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Cees Wortels erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Finance